Multifunctional polymeric micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug delivery

2005 ◽  
Vol 1 (3) ◽  
pp. 242 ◽  
Author(s):  
Younsoo Bae ◽  
Woo-Dong Jang ◽  
Nobuhiro Nishiyama ◽  
Shigeto Fukushima ◽  
Kazunori Kataoka
Nano Research ◽  
2015 ◽  
Vol 9 (1) ◽  
pp. 139-148 ◽  
Author(s):  
Yu Yang ◽  
Jingjing Liu ◽  
Xiaoqi Sun ◽  
Liangzhu Feng ◽  
Wenwen Zhu ◽  
...  

2010 ◽  
Vol 28 (2) ◽  
pp. 301-308 ◽  
Author(s):  
Rupa R. Sawant ◽  
Onkar Vaze ◽  
Gerard G. M. D’Souza ◽  
Karen Rockwell ◽  
Vladimir P. Torchilin

2019 ◽  
Vol 206 ◽  
pp. 694-705 ◽  
Author(s):  
Manita Das ◽  
Archana Solanki ◽  
Apeksha Joshi ◽  
Ranjitsinh Devkar ◽  
Sriram Seshadri ◽  
...  

Oncotarget ◽  
2017 ◽  
Vol 8 (63) ◽  
pp. 107176-107187 ◽  
Author(s):  
Kylie Van Hoesen ◽  
Sonia Meynier ◽  
Pascale Ribaux ◽  
Patrick Petignat ◽  
Florence Delie ◽  
...  

2018 ◽  
Vol 5 (1) ◽  
pp. 170986 ◽  
Author(s):  
Yang Zhang ◽  
Juan Xu

This paper proposes a novel type of multifunctional envelope-type mesoporous silica nanoparticle (MSN) to achieve cancer cell targeting and drug-controlled release. In this system, MSNs were first modified by active targeting moiety hyaluronic acid (HA) for breast cancer cell targeting and hyaluronidases (Hyal)-induced intracellular drug release. Then gelatin, a proteinaceous biopolymer, was grafted onto the MSNs to form a capping layer via glutaraldehyde-mediated cross-linking. To shield against unspecific uptake of cells and prolong circulation time, the nanoparticles were further decorated with poly(ethylene glycol) polymers (PEG) to obtain MSN@HA-gelatin-PEG (MHGP). Doxorubicin (DOX), as a model drug, was loaded into PEMSN to assess the breast cancer cell targeting and drug release behaviours. In vitro study revealed that PEG chains protect the targeting ligand and shield against normal cells. After reaching the breast cancer cells, MMP-2 overpressed by cells hydrolyses gelatin layer to deshield PEG and switch on the function of HA. As a result, DOX-loaded MHGP was selectively trapped by cancer cells through HA receptor-mediated endocytosis and subsequently release DOX due to Hyal-catalysed degradation of HA. This system presents successful bienzyme-responsive targeting drug delivery in an optimal fashion and provides potential applications for targeted cancer therapy.


2015 ◽  
Vol 73 ◽  
pp. 216-220 ◽  
Author(s):  
Pavel Linkov ◽  
Marie Laronze-Cochard ◽  
Janos Sapi ◽  
Lev N. Sidorov ◽  
Igor Nabiev

Sign in / Sign up

Export Citation Format

Share Document